Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
Changes to healthcare legislation
January 13, 2026
A summary of the provincial government’s latest legislative changes and how they may impact regulated members.
Read more ➞
